BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
95.50
+3.52 (3.83%)
At close: Apr 10, 2026, 4:00 PM EDT
95.00
-0.50 (-0.52%)
After-hours: Apr 10, 2026, 4:56 PM EDT
BioNTech SE Market Cap
BioNTech SE has a market cap or net worth of $24.15 billion as of April 10, 2026. Its market cap has increased by 3.70% in one year.
Market Cap
24.15B
Enterprise Value
8.33B
1-Year Change
3.70%
Ranking
Category
Stock Price
$95.50
Market Cap Chart
Since October 10, 2019, BioNTech SE's market cap has increased from $2.99B to $24.15B, an increase of 706.36%. That is a compound annual growth rate of 37.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 23.26B | 1.61% |
| Dec 31, 2025 | 22.89B | -16.21% |
| Dec 31, 2024 | 27.32B | 8.89% |
| Dec 29, 2023 | 25.09B | -31.28% |
| Dec 30, 2022 | 36.51B | -41.37% |
| Dec 31, 2021 | 62.26B | 217.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 34.73B |
| Insmed | 34.15B |
| Royalty Pharma | 27.76B |
| Roivant Sciences | 20.25B |
| Moderna | 20.23B |
| Incyte | 19.15B |
| Revolution Medicines | 18.98B |
| Genmab | 17.32B |